Relapsed thrombotic thrombocytopenic purpura presenting as an acute cerebrovascular accident

Journal of Clinical Apheresis

Volumn 19, Issue 2, 2004, Pages 86-89

  Downes, Katharine A ^a   Yomtovian, Roslyn ^a   Tsai, H M ^c   Silver, Bernard ^b   Rutherford, Cynthia ^d   Sarode, Ravindra ^e  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d Univ Texas Southwestern Med Ctr ^*  (United States)

^e UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

ADAMTS13 protease activity; Cerebrovascular accident; Stroke; Therapeutic plasma exchange; Thrombotic thrombocytopenic purpura

Indexed keywords

HEMOGLOBIN; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ADULT; ARTICLE; CASE REPORT; CEREBROVASCULAR ACCIDENT; CLINICAL FEATURE; FEMALE; HEMOGLOBIN DETERMINATION; HEMOLYTIC ANEMIA; HUMAN; MAGNETIC RESONANCE ANGIOGRAPHY; MICROANGIOPATHY; NEUROLOGIC DISEASE; PLASMAPHERESIS; RELAPSE; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ADAM PROTEINS; ADULT; CEREBROVASCULAR ACCIDENT; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; METALLOENDOPEPTIDASES; PURPURA, THROMBOTIC THROMBOCYTOPENIC; RECURRENCE; THROMBOCYTOPENIA; TIME FACTORS;

EID: 3442881602     PISSN: 07332459     EISSN: None     Source Type: Journal    
DOI: 10.1002/jca.20007     Document Type: Article

References (9)

1. Druschky A, Erbguth F, Strauss R, Helm G, Heckmann J, Neundorfer B. Central nervous system involvement in thrombotic thrombocytopenic purpura. Eur Neurol 1998;40:220-224.
2. Sarode R, Gottschall JL, Aster RH, McFarland J. Thrombotic thrombocytopenic purpura: early and late responders. Am J Hematol 1997;54:102-107.
3. Tsai HM, Lian EC. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med 1998;339:1585-1594.
4. Tsai HM, Li A, Rock G. Inhibitors of von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura. Clin Lab 2001;47:387-392.
5. Furlan M, Robles R, Galbusera M, Remuzzi G, Kyrle PA, Brenner B, Krause M, Scharrer I, Aumann V, Mittler U, Solenthaler M, Lammle B. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med 1998;339:1578-1584.
6. Veyradier A, Obert B, Houllier A, Meyer D, Girma JP. Specific von Willebrand factor-cleaving protease in thrombotic microangiopathies: a study of 111 cases. Blood 2001;98:1765-1772.
7. Levy G, Nichols WC, Lian EC, Foroud T, McClintick JN, McGee BM, Yang AY, Siemieniak DR, Stark KR, Gruppo R, Sarode R, Shurin SB, Chandrasekaran V, Stabler SP, Sabio H, Bouhassira EE, Upshaw JD Jr, Ginsburg D, Tsai HM. Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature 2001;413:488-494.
8. Tsai HM. Advances in the pathogenesis, diagnosis, and treatment of thrombotic thrombocytopenic purpura. Am Soc Nephrol 2003;14:1072-1081.
9. Tsai HM, Shulman K. Rituximab induces remission of cerebral ischemia caused by thrombotic thrombocytopenic purpura. Eur J Hematol 2003;70:183-185.